cognitive cybersecurity intelligence

News and Analysis

Search

Reimagining the FDA’s Role in Digital Medicine

The FDA should allocate more resources to assessing the efficacy and quality of software as a medical device (SaMD), on top of its safety evaluations. The call comes after a review of approvals found most were based on retrospective studies, with none of the high-risk devices assessed by prospective trials. Mayo Clinic is considering a more holistic approach to evaluating SaMD, involving a standard labelling schema documenting system characteristics, intended use and performance measures.

Source: geekdoctor.blogspot.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts